From: Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
Grade 1
Grade 2
Grade 3
Leukopenia
1
3
-
Neutropenia
Nausea/Vomiting
2
Mucositis
Transaminases
4
Asthenia
Cardiac
0